ROCKETing Forward: The Future of Atopic Dermatitis Treatment Targeting the OX40 Signalling Pathway - European Medical Journal

ROCKETing Forward: The Future of Atopic Dermatitis Treatment Targeting the OX40 Signalling Pathway

Dermatology
Download PDF

This infographic summarises the data presented at the European Academy of Dermatology and Venereology (EADV) 2023 symposium, sponsored by Amgen and Kyowa Kirin.

Please rate the quality of this content

As you found this content interesting...

Follow us on social media!

We are sorry that this content was not interesting for you!

Let us improve this content!

Tell us how we can improve this content?

Keep your finger on the pulse

Join Now

Elevating the Quality of Healthcare Globally

>